52J-16072-98162
2 vaccinations
6 coded responses
20 check-ins
6 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 191 / PA
- Registered
- 2021-02-18
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-16
Dose 1 — Pfizer-BioNTech
-
2021-02-18
Registered in v-safe
-
2021-02-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · Muscle or body achesAdult check-in
-
2021-02-20
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: Good · Joint pains, Muscle or body achesFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-21
-
2021-02-22
Survey response — days 1–6 daily, dose 1MedDRA: Chills, Muscle disorder, Sensitisation — Feeling: GoodFree text: Not easy in cold weather to tell whether muscles issues, joint sensitivity, cold chills are caused by the cold or vaccine. But exercising 1st time says muscles get sore fasterMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-23
Survey response — day 7, dose 1MedDRA: Unevaluable event — Feeling: GoodFree text: Muscles, joints and chills diminishing as weather warms, so if anything vaccine contribution minimalMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-03
-
2021-03-09
Dose 2 — Pfizer-BioNTech
-
2021-03-09
Health check-in — day 0, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
-
2021-03-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
- 2021-03-11
- 2021-03-12
-
2021-03-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Swelling · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-03-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-03-16
Survey response — day 7, dose 2MedDRA: Rash — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Fading rashesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-23
- 2021-03-31
-
2021-04-09
Survey response — day 28, dose 2MedDRA: Rash pruritic — Feeling: GoodFree text: Lingering rashes (2) that itch; new rashes that dont itch. Not easily attributed to the sun. Will observeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-21
Survey response — day 42, dose 2MedDRA: Rash — Feeling: GoodFree text: The rashes, although few, are persistent and hasnt disappeared. These are the ones that appeared after vaccination.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-10
- 2021-09-11
- 2022-03-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-16 | Pfizer-BioNTech | |
| 2 | 2021-03-09 | Pfizer-BioNTech |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): No
Systemic reaction (other): Not easy in cold weather to tell whether muscles issues, joint sensitivity, cold chills are caused by the cold or vaccine. But exercising 1st time says muscles get sore faster
Release 4 — day 7, dose 1
Systemic reaction (other): Muscles, joints and chills diminishing as weather warms, so if anything vaccine contribution minimal
Release 5 — day 7, dose 2
Systemic reaction (other): Fading rashes
Release 7 — day 28, dose 2
Symptoms: Lingering rashes (2) that itch; new rashes that dont itch. Not easily attributed to the sun. Will observe
Release 7 — day 42, dose 2
Symptoms: The rashes, although few, are persistent and hasnt disappeared. These are the ones that appeared after vaccination.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Rash pruritic | ✓ | ✓ | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Muscle disorder | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Sensitisation | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release